These stocks led the market higher. Find out why.
News & Analysis: Spectranetics
Investors hit the jackpot with cardiac-care stocks last year. Here are three stocks primed to continue the heart-stopping gains.
A solid earnings report sends shares higher, but is the company a buy after this report?
Disappointing guidance for the rest of the year caused shares of Spectranetics to fall hard.
A tepid first quarter and disappointing guidance caused The Spectranetics Corporation shares to trade lower.
Shares of this medical device maker shot up by more than 10% early after a big FDA approval
Don't just count the cash, time it.
Don't just ask, "How much inventory?" Ask, "What kind?"
Just the facts, Fool.